A comparative study on effect of platelet rich plasma Vs conventional dressing in healing rate of chronic diabetic ulcers
Keywords:Diabetic ulcer, platelet rich plasma therapy, diabetic foot, wound healing, chronic diabetic wound healing, non-healing ulcer
Introduction and Aim: This study has been undertaken to evaluate efficacy of platelet rich plasma (PRP) dressing that is recently introduced with conventional dressing. We have tried to compare PRP dressing with conventional normal dressing in healing the wound.
Materials and Methods: We conducted this study in 120 patients of chronic non healing diabetic foot ulcers who were treated over the period of three years. Number of cases (60 each) were studied for efficacy of applying autologous platelet rich plasma versus normal dressing for chronic non healing diabetic foot ulcers. At every week follow up, the ulcer was examined for granulation tissue, area and volume which was calculated using Vernier calipers and marked on a graph paper and photographs were taken. Wound healing was compared between PRP and normal dressing.
Results: The incidence of male susceptibility was more (70%) than females (30%) in diabetic foot. Average rate of healing per week was found to be significantly better among the PRP group than normal dressing group. The ulcer showed significant reduction in size among the PRP group in comparison to the normal dressing group with a significant P value (0.001).
Conclusion: In this study application of platelet rich plasma into chronic non-healing diabetic foot ulcers in comparison with conventional dressing has shown a significant reduction in the size of the ulcer, hospital stay and cost for the patient.
Saltmarche, A. E. Low level laser therapy for healing acute and chronic wounds-the extendicare experience. International Wound Journal, 2008; 5(2): 351-360.
Bitsch, M., Bitsch, M., Laursen, I., Engel, A. M., Christiansen, M., Larsen, S.O., et al., Epidemiology of chronic wound patients and relation to serum levels of mannan-binding lectin. Acta Derm Venereol. 2009; 89(6): 607-611. doi: 10.2340/00015555-0730.
Gottrup, F. Optimizing wound treatment through health care structuring and professional education. Wound Repair Regen. 2004 Mar-Apr;12(2): 129-133. doi: 10.1111/j.1067-1927.2004.012204. x.
Bennett, N. T., Schultz, G. S. Growth factors and wound healing: Part II. Role in normal and chronic wound healing. Am J Surg. 1993 Jul; 166(1): 74-81. doi: 10.1016/s0002-9610(05)80589-6.
Crovetti, G., Martinelli, G., Issi, M., Barone, M., Guizzardi, M., Campanati, B., et al., Platelet gel for healing cutaneous chronic wounds. Transfus Apher Sci. 2004 Apr; 30(2): 145-151. doi: 10.1016/j.transci.2004.01.004.
Davis, M. D. P., Felty, C. L., Liedl, D. A., Pineda, A. A., Moore, S. B., Rooke, T. W. Autologous platelet lysate product versus placebo in patients with chronic leg ulcerations: A pilot study using a randomized, double-blind, placebo-controlled trial. Wounds, 2004; 16(9): 273-282.
Herouy, Y., Mellios, P., Bandemir. E., Stetter, C., Dichmann, S., Idzko, M., et al., Autologous platelet-derived wound healing factor promotes angiogenesis via alphavbeta 3-integrin expression in chronic wounds. Int J Mol Med. 2000; Nov; 6(5): 515-519. doi: 10.3892/ijmm.6.5.515.
Glover, J. L., Weingarten, M. S., Buchbinder, D. S., Poucher, R. L., Deitrick, G. A., ill, Fylling. CPA 4-year outcome-based retrospective study of wound healing and limb salvage in patients with chronic wounds. Adv Wound Care. 1997; 10: 33-38.
Margolis, D. J., Kantor, J., Santanna, J., Strom, B. L., Berlin, J. A. Effectiveness of platelet release at the treatment of diabetic neuropathic foot ulcers. Diabetes Care. 2001; Mar; 24(3): 483-488. doi: 10.2337/diacare.24.3.483. PMID: 11289472.
Lindemann, S., Tolley, N. D., Dixon, D. A., McIntyre, T. M., Prescott, S. M., Zimmerman, G. A., et al., Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis. J Cell Biol. 2001; Aug 6;154(3):485-490. doi: 10.1083/jcb.200105058. PMID:
Dankert, J., Krijgsveld, J., van Der Werff, J., Joldersma, W., Zaat, S. A. Platelet microbicidal activity is an important defense factor against viridans streptococcal endocarditis. J Infect Dis. 2001; 184(5): 597-605. doi: 10.1086/322802.
Eisenbud, D., Huang, N.F., Luke, S., Silberklang, M. Skin substitutes and wound healing: Current status and challenges. Wounds. 2004; Vol.16: 2 -17.
Wagner, F.W. Jr. The diabetic foot. Orthopedics. 1987; 10: 163-172.
Aristidis Veveshe, Giurini, J. M., Guzman, R. J. The diabetic foot-Medical and Surgical Management. 2002; 2:37.
Aristidis Vevese. The diabetic foot- Medical and Surgical Management edited by Aristidis Veves, 2002; 1: 18-19.
Banu, A., Noorul Hassan, M.M., Rajkumar, J., Srinivasa, S. Spectrum of bacteria associated with diabetic foot ulcer and biofilm formation: A prospective study. AMJ 2015; 8(9): 280-285.
Qaseem, A., Humphrey, L. L., Forciea, M. A., Starkey, M., Denberg, T. D. Clinical Guidelines Committee of the American College of Physicians. Treatment of pressure ulcers: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2015 Mar 3; 162(5): 370-379.
Goode, P. S. Consensus on wound debridement. A United States perspective. Eur tissue Rep-SOC. 1995; 2: 104.
Knighton, D. R. 1., Ciresi, K., Fiegel, V. D., Schumerth, S., Butler, E., Cerra, F. Surg Gynecol Obstet, 1990; 170(1): 56-60.
Villela, D. L., Santos, V. L. Evidence on the use of platelet-rich plasma for diabetic ulcer: a systematic review. Growth Factors. 2010; 28(2): 111-116.
Saad Setta, H., Elshahat, A., Elsherbiny, K., Massoud, K., Safe, I. Platelet-rich plasma versus platelet-poor plasma in the management of chronic diabetic foot ulcers: a comparative study. Int Wound J. 2011; Jun; 8(3): 307-312. doi: 10.1111/j.1742-481X.2011.00797.x.
How to Cite
Copyright (c) 2021 Biomedicine
This work is licensed under a Creative Commons Attribution 4.0 International License.